|
|
|
<< Back to Financial Strength by Company within Major Pharmaceutical Preparations Industry
Major Pharmaceutical Preparations Industry Financial Strength Information
|
Financial Strength Information & Trends  |
|
|
|
Industry: Major Pharmaceutical Preparations ▼
|
Category:
|
|
|
|
Major Pharmaceutical Preparations ▼
|
| Major Pharmaceutical Preparations Industry |
2 Q |
1 Q |
4 Q |
3 Q |
2 Q |
|
|
Q2 2025 |
Q1 2025 |
Q4 2024 |
Q3 2024 |
Q2 2024 |
| Quick Ratio (TTM) |
1.05 |
0.53 |
0.52 |
0.55 |
0.6 |
| Quick Ratio Ranking |
# 4 |
# 25 |
# 31 |
# 27 |
# 27 |
| Working Capital Ratio (TTM) |
6.2 |
1.4 |
1.41 |
1.41 |
1.47 |
| Working Capital Ratio Ranking |
# 1 |
# 38 |
# 41 |
# 39 |
# 42 |
| Working Capital Per Revenue |
5.15 |
0.21 |
0.22 |
0.22 |
0.25 |
| Working Capital Per Revenue Ranking |
# 26 |
# 84 |
# 86 |
# 84 |
# 85 |
| Leverage Ratio (TTM) |
0.3 |
2.02 |
1.76 |
1.95 |
1.89 |
| Leverage Ratio Ranking |
# 3 |
# 51 |
# 47 |
# 48 |
# 47 |
| Total Debt to Equity (TTM) |
- |
1.06 |
0.88 |
1.03 |
0.99 |
| Total Debt to Equity Ranking |
# 5 |
# 67 |
# 67 |
# 65 |
# 65 |
| Interest Coverage (TTM) |
- |
21.47 |
14.53 |
15.77 |
14.13 |
| Interest Coverage
Ranking |
# 7 |
# 42 |
# 32 |
# 42 |
# 40 |
| Debt Coverage (TTM) |
- |
0.31 |
0.25 |
0.26 |
0.24 |
| Debt Coverage Ranking |
# 7 |
# 58 |
# 71 |
# 75 |
# 70 |
| Quick Ratio Comment |
On the trailing twelve months basis Current Liabilities decreased faster than Major Pharmaceutical Preparations Industry's Cash & cash equivalent, this led to an improvemen in Major Pharmaceutical Preparations Industry's Quick Ratio to 1.05 in the Q2 2025,, above Major Pharmaceutical Preparations Industry average Quick Ratio.
Within Healthcare sector, Major Pharmaceutical Preparations Industry achieved the highest Quick Ratio. Quick Ratio total ranking has improved so far to 4, from total ranking in previous quarter at 25. |
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.
| Quick Ratio Statistics as of Q2 2025 |
| High |
Average |
Low |
| 5.88 |
1 |
0.52 |
| 1. quarter 2016 |
|
4. quarter 2024 |
| Quick Ratio Industry Ranking |
| Within: |
No. |
| Sector |
# 1 |
| Overall |
# 4
|
| Major Pharmaceutical Preparations Industry Working Capital Ratio Statistics as of Q2 2025 |
|
|
|
| Working Capital Ratio Statistics as of Q2 2025 |
| High |
Average |
Low |
| 6.2 |
1.89 |
1.4 |
| 2. quarter 2025 |
|
1. quarter 2025 |
| Working Capital Ratio Comment |
On the trailing twelve months basis Major Pharmaceutical Preparations Industry's Current Assets grew by 2.91 % in the Q2 2025 sequentially, while Current Liabilities decreased, this led to an improvemen in Industry's Working Capital Ratio to 6.2 in the 2 Q 2025 a new Industry high.
Within Healthcare sector, Major Pharmaceutical Preparations Industry accomplished the highest Working Capital Ratio. Working Capital Ratio total ranking has improved to 1, from total ranking in previous quarter at 38.
|
| Working Capital Ratio Industry Ranking |
| Within: |
No. |
| Sector |
# 1 |
| Overall |
# 1
|
|
| Major Pharmaceutical Preparations Industry Working Capital Per Revenue Statistics as of Q2 2025 |
|
|
| Working Capital Per Revenue Comment |
On the trailing twelve months basis Major Pharmaceutical Preparations Industry's Working Capital Per Revenue sequentially grew to 5.15 in the Q2 2025, above Industry average.
Within Healthcare sector, Major Pharmaceutical Preparations Industry achieved lowest Working Capital Per Revenue. Working Capital Per Revenue total ranking has improved to 26, from total ranking in previous quarter at 84.
|
| Working Capital Per Revenue Statistics as of Q2 2025 |
| High |
Average |
Low |
| 5.11 |
0.43 |
0.12 |
| 2. quarter 2025 |
|
1. quarter 2016 |
| Working Capital Per Revenue Industry Ranking |
| Within: |
No. |
| Sector |
# 1 |
| Overall |
# 26
|
|
|
| Major Pharmaceutical Preparations Industry Leverage Ratio Statistics as of Q2 2025 |
|
|
|
|
| Leverage Ratio Statistics as of Q2 2025 |
| High |
Average |
Low |
| 2.02 |
1.44 |
-0.51 |
| 1. quarter 2025 |
|
1. quarter 2016 |
| Leverage Ratio Comment |
Due to liability repayments of 0.88% Industry improved liabilities-to-equity-ratio in Q2 2025 to 0.3, below Industry average.
, Major Pharmaceutical Preparations Industry achieved lowest Leverage Ratio.
Leverage Ratio total ranking has improved so far to 3, from overall ranking in the previous quarter at 51.
|
| Leverage Ratio Industry Ranking |
| Within: |
No. |
| Sector |
# 1 |
| Overall |
# 3
|
|
| Major Pharmaceutical Preparations Industry Total Debt to Equity Ratio Statistics as of Q2 2025 |
|
|
| Debt to Equity Ratio Comment |
| | | | |
